Come up with a name for your new list and we'll add to it:
eXIthera Pharmaceuticals raised a round of funding on July 31, 2012. Investors include
Access BridgeGap Ventures.
eXIthera Pharmaceuticals is a an early stage biotech company focused on developing small molecule pharmaceuticals to inhibit Factor Xla, an important enzyme in the blood coagulation pathway.…